REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Delpharm Investments Poland Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Publishers | Data Processing, Hosting, and Related Services | Other Information Services | Internet Publishing and Broadcasting and Web Search Portals | Other Activities Related to Credit Intermediation | Offices of Real Estate Agents and Brokers | Computer Systems Design and Related Services | Advertising, Public Relations, and Related Services | Telephone Call Centers
Full name: Delpharm Investments Poland Sp. z o.o. Profile Updated: May 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Delpharm Investments Poland Sp. z o.o. is a company based in Poland, with its head office in Poznan. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was incorporated on April 25, 2018. The latest financial highlights indicate a net sales revenue drop of 100% in 2023. Its’ total assets recorded a negative growth of 0.53%.

Headquarters
Ul. Grunwaldzka 189
Poznan; Wielkopolskie; Postal Code: 60-322

Contact Details: Purchase the Delpharm Investments Poland Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Delpharm Investments Poland Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Delpharm Investments Poland Sp. z o.o. report to view the information.
Incorporation Date:
April 25, 2018
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Delpharm Investments Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-100%▼
Total operating revenue
39.5%▲
Operating profit (EBIT)
N/A
EBITDA
137.1%▲
Net Profit (Loss) for the Period
N/A
Total assets
-0.53%▼
Total equity
N/A
Return on Equity (ROE)
182.84%▲

Similar companies

Adamed Pharma S.A.
 
"Przedsiebiorstwo Produkcji Farmaceutycznej Hasco - Lek" S.A.
Tarchominskie Zaklady Farmaceutyczne "Polfa" S.A.
 
Ziaja Ltd Zaklad Produkcji Lekow Sp. z o.o.
Maco Productions Polonia Sp. z o.o.
 
Orifarm Manufacturing Poland Sp. z o.o.
Pharmfactor Sp. z o.o.
 
Akademia Boreliozy Sp. z o.o.
Figuraline Sp. z o.o.
 
F1 Pharma S.A.
Paradise Company Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo